4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002554
Options or other derivatives
- PRESIDENT AND CEO acquired 992,409 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Aggarwal Sumit · PRESIDENT AND CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-18 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +992,409 | 992,409 | D |
Loading xslF345X03/form4-05182021_050501.xml…